<--- Back to Details
First PageDocument Content
Coagulation system / Blood products / Organochlorides / Transfusion medicine / Nephrology / Thrombotic thrombocytopenic purpura / Clopidogrel / Ticlopidine / Hemolytic-uremic syndrome / Blood / Medicine / Anatomy
Date: 2015-04-17 12:39:38
Coagulation system
Blood products
Organochlorides
Transfusion medicine
Nephrology
Thrombotic thrombocytopenic purpura
Clopidogrel
Ticlopidine
Hemolytic-uremic syndrome
Blood
Medicine
Anatomy

Journal of the Hong Kong Geriatrics Society • Vol. 10 No.2 JulyAN ELDERLY GENTLEMAN WITH SUSPECTED RECURRENT STROKE AND TICLOPIDINE INDUCED THROMBOTIC THROMBOCYTOPENIC PURPURA YW Shum. MBBS (HK), MRCP (UK), FHKA

Add to Reading List

Source URL: www.hkgs.org

Download Document from Source Website

File Size: 55,61 KB

Share Document on Facebook

Similar Documents

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

DocID: 1vj68 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uEgV - View Document

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics  September 29-30, 2016 Orlando, USA

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA

DocID: 1uvE8 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uvxq - View Document

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

DocID: 1tmLJ - View Document